Join our panel as perspectives are shared on what the revisions mean, how changes impact patient care, and tips can be employed to help achieve compliance.
On the cUSP of Enforcement: USP <797> Revisions and Strategies
On the cUSP of Enforcement: USP 797 Revisions and Strategies
Craig Greszler will moderate a panel of three distinguished panelists discussing the United States Pharmacopeia (USP) latest draft revisions to chapter <797> on 11/1/2022. This gives compounding entities a full year to adopt changes before they become official (expected 11/1/2023).
With only a few months remaining before regulators can enforce these changes, it is imperative that compounding entities across the nation develop a plan for complying. Join this panel of compounding experts as they share their perspectives on what the revisions mean, how changes impact patient care, and tips and tricks you may employ to help achieve compliance.
USP <797> Revisions and Strategies